Skip to main content
Year archive

Kintor Pharmaceutical Limited — 2025 filings

All 43 regulatory filings released by Kintor Pharmaceutical Limited (9939) in 2025, sourced directly from the official regulator.

43 Filings
2025 Period
2025 filings (43)
Filing Released Lang
(1) RESIGNATION OF NON-EXECUTIVE DIRECTOR&#x3b; AND (2) APPOINTMENT OF NON-EXECUTIVE DIRECTOR
Board/Management Information
2025-12-11 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information
2025-12-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Share Issue/Capital Change
2025-12-01 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-11-21 English
COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change
2025-11-21 English
SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2025-11-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Share Issue/Capital Change
2025-11-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Share Issue/Capital Change
2025-10-03 English
INTERIM REPORT 2025
Interim / Quarterly Report H2 2025
2025-09-26 English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF ENROLLMENT OF SUBJECTS IN LONG-TERM HUMAN SAFETY TRIAL OF KT-939
Regulatory Filings
2025-09-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Regulatory Filings
2025-09-02 English
(1) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025&#x3b; AND (2) FURTHER CHANGE IN USE OF PROCEEDS FROM THE TOP-UP PLACING 2022
Interim / Quarterly Report H1 2025
2025-08-28 English
DATE OF BOARD MEETING
Report Publication Announcement
2025-08-15 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-08-14 English
COMPLETION OF TOP-UP PLACING OF EXISTING SHARES AND SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change
2025-08-14 English
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF GT20029 GEL FOR THE TREATMENT OF ACNE IN CHINA REACHED PRIMARY ENDPOINT
Regulatory Filings
2025-08-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
Regulatory Filings
2025-08-01 English
(1) TOP-UP PLACING OF EXISTING SHARES AND (2) SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change
2025-08-01 English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF PATIENT ENROLLMENT IN PHASE III STAGE OF PIVOTAL CLINICAL TRIAL OF KX-826 TINCTURE 1.0% FOR THE TREATMENT OF MALE ADULT AGA IN CHINA
Regulatory Filings
2025-07-31 English
VOLUNTARY ANNOUNCEMENT - PHASE II STAGE OF PIVOTAL CLINICAL TRIAL OF KX-826 TINCTURE 1.0% FOR THE TREATMENT OF MALE ADULT AGA IN CHINA REACHED PRIMARY ENDPOINT
Regulatory Filings
2025-07-24 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
Regulatory Filings
2025-07-02 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2025-06-26 English
CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE
Board/Management Information
2025-06-26 English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE
Governance Information
2025-06-26 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON TUESDAY, 10 JUNE 2025
Declaration of Voting Results & Voting Rights Announcements
2025-06-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Regulatory Filings
2025-06-04 English
(1) RE-ELECTION OF RETIRING DIRECTORS&#x3b; (2) RE-APPOINTMENT OF AUDITOR&#x3b; (3) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; AND (4) NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-05-13 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2025-05-13 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-05-13 English
VOLUNTARY ANNOUNCEMENT - OFFICIAL COMMENCEMENT OF GLOBAL SALES BUSINESS OF WHITENING AND FRECKLE-REMOVING FUNCTIONAL COSMETIC RAW MATERIAL KT-939
Regulatory Filings
2025-05-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
Regulatory Filings
2025-05-06 English
VOLUNTARY ANNOUNCEMENT - SUPERIOR EFFICACY OF CLINICAL OBSERVATIONAL STUDY IN KX-826 IN COMBINATION WITH MINOXIDIL FOR THE TREATMENT OF MALE ADULTS WITH AGA IN CHINA OVER MINOXIDIL MONOTHERAPY
Regulatory Filings
2025-05-02 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024
Environmental & Social Information
2025-04-29 English
ANNUAL REPORT 2024
Annual Report FY 2024
2025-04-29 English
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY CHAIRMAN OF THE BOARD, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER DR. YOUZHI TONG BY 1,450,000 SHARES
Director's Dealing
2025-04-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
Regulatory Filings
2025-04-03 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
Annual Report
2025-03-26 English
VOLUNTARY ANNOUNCEMENT - LONG-TERM SAFETY PHASE III CLINICAL TRIAL OF KX-826 FOR THE TREATMENT OF AGA REACHED PRIMARY ENDPOINT
Regulatory Filings
2025-03-20 English
VOLUNTARY ANNOUNCEMENT - OPERATION COOPERATION AGREEMENT IN RELATION TO OVERSEAS MARKET OF COSMETICS
Regulatory Filings
2025-03-12 English
DATE OF BOARD MEETING
Regulatory Filings
2025-03-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
Regulatory Filings
2025-03-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
Share Issue/Capital Change
2025-02-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
Regulatory Filings
2025-01-03 English